Literature DB >> 12601346

HCC surveillance: who is the target population?

Jordi Bruix, Josep M Llovet.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12601346     DOI： 10.1053/jhep.2003.50142

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  11 in total

1.  Hepatocellular carcinoma: review of current treatment with a focus on targeted molecular therapies.

Authors:  Sonja K Olsen; Robert S Brown; Abby B Siegel
Journal:  Therap Adv Gastroenterol       Date:  2010-01       Impact factor: 4.409

2.  Sixty-five gene-based risk score classifier predicts overall survival in hepatocellular carcinoma.

Authors:  Soo Mi Kim; Sun-Hee Leem; In-Sun Chu; Yun-Yong Park; Sang Cheol Kim; Sang-Bae Kim; Eun Sung Park; Jae Yun Lim; Jeonghoon Heo; Yoon Jun Kim; Dae-Ghon Kim; Ahmed Kaseb; Young Nyun Park; Xin Wei Wang; Snorri S Thorgeirsson; Ju-Seog Lee
Journal:  Hepatology       Date:  2012-03-18       Impact factor: 17.425

3.  Transarterial chemoembolization (TACE) plus percutaneous ethanol injection (PEI) for the treatment of unresectable hepatocellular carcinoma: a meta-analysis of randomized controlled trials.

Authors:  Yang Fu; Xu Zhao; Qiang Yun; Xueming Zhu; Yong Zhu; Quanwang Li; Kaiwen Hu; Jinwan Wang; Zhanbing Qiao
Journal:  Int J Clin Exp Med       Date:  2015-07-15

4.  Incidence of hepatocellular carcinoma among US patients with cirrhosis of viral or nonviral etiologies.

Authors:  Robert D Mair; Antonia Valenzuela; Nghiem B Ha; Walid S Ayoub; Tami Daugherty; Glen A Lutchman; Gabriel Garcia; Aijaz Ahmed; Mindie H Nguyen
Journal:  Clin Gastroenterol Hepatol       Date:  2012-08-16       Impact factor: 11.382

5.  Rapid induction of orthotopic hepatocellular carcinoma in immune-competent rats by non-invasive ultrasound-guided cells implantation.

Authors:  Hoi-Hung Chan; Tian-Huei Chu; Hsin-Fan Chien; Cheuk-Kwan Sun; E-Ming Wang; Huay-Ben Pan; Hsiao-Mei Kuo; Tsung-Hui Hu; Kwok-Hung Lai; Jiin-Tsuey Cheng; Ming-Hong Tai
Journal:  BMC Gastroenterol       Date:  2010-07-22       Impact factor: 3.067

6.  Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis.

Authors:  Cristina Ripoll; Roberto J Groszmann; Guadalupe Garcia-Tsao; Jaime Bosch; Norman Grace; Andrew Burroughs; Ramon Planas; Angels Escorsell; Juan Carlos Garcia-Pagan; Robert Makuch; David Patch; Daniel S Matloff
Journal:  J Hepatol       Date:  2009-03-05       Impact factor: 25.083

7.  SC-2001 overcomes STAT3-mediated sorafenib resistance through RFX-1/SHP-1 activation in hepatocellular carcinoma.

Authors:  Jung-Chen Su; Ping-Hui Tseng; Szu-Hsien Wu; Cheng-Yi Hsu; Wei-Tien Tai; Yong-Shi Li; I-Ting Chen; Chun-Yu Liu; Kuen-Feng Chen; Chung-Wai Shiau
Journal:  Neoplasia       Date:  2014-07-18       Impact factor: 5.715

8.  Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells.

Authors:  W-T Tai; C-W Shiau; H-L Chen; C-Y Liu; C-S Lin; A-L Cheng; P-J Chen; K-F Chen
Journal:  Cell Death Dis       Date:  2013-02-07       Impact factor: 8.469

9.  Targeting Phosphatidylinositide3-Kinase/Akt pathway by BKM120 for radiosensitization in hepatocellular carcinoma.

Authors:  Wei-Lin Liu; Ming Gao; Kai-Yuan Tzen; Chiao-Ling Tsai; Feng-Ming Hsu; Ann-Lii Cheng; Jason Chia-Hsien Cheng
Journal:  Oncotarget       Date:  2014-06-15

10.  Combination Therapy of Radiofrequency Ablation and Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Retrospective Study.

Authors:  Chengwu Tang; Jian Shen; Wenming Feng; Ying Bao; Xiaogang Dong; Yi Dai; Yinyuan Zheng; Jianping Zhang
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.